AR028002A1 - Metodos para la produccion de ansamitocina - Google Patents
Metodos para la produccion de ansamitocinaInfo
- Publication number
- AR028002A1 AR028002A1 ARP010101696A ARP010101696A AR028002A1 AR 028002 A1 AR028002 A1 AR 028002A1 AR P010101696 A ARP010101696 A AR P010101696A AR P010101696 A ARP010101696 A AR P010101696A AR 028002 A1 AR028002 A1 AR 028002A1
- Authority
- AR
- Argentina
- Prior art keywords
- ansamitocine
- production
- methods
- ansamitocine production
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19636100P | 2000-04-12 | 2000-04-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR028002A1 true AR028002A1 (es) | 2003-04-23 |
Family
ID=22725075
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010101696A AR028002A1 (es) | 2000-04-12 | 2001-04-10 | Metodos para la produccion de ansamitocina |
Country Status (21)
Country | Link |
---|---|
US (2) | US6573074B2 (es) |
EP (1) | EP1272653B1 (es) |
JP (1) | JP4832697B2 (es) |
KR (1) | KR20030036159A (es) |
CN (1) | CN1432068A (es) |
AR (1) | AR028002A1 (es) |
AT (1) | ATE331804T1 (es) |
AU (2) | AU9333501A (es) |
BR (1) | BR0109975A (es) |
CA (1) | CA2406188A1 (es) |
CZ (1) | CZ20023356A3 (es) |
DE (1) | DE60121150T2 (es) |
ES (1) | ES2266243T3 (es) |
HU (1) | HUP0300473A3 (es) |
IL (1) | IL152241A0 (es) |
MX (1) | MXPA02010109A (es) |
NO (1) | NO20024893D0 (es) |
NZ (1) | NZ521868A (es) |
PL (1) | PL365577A1 (es) |
WO (1) | WO2001077360A2 (es) |
ZA (1) | ZA200208159B (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6333410B1 (en) | 2000-08-18 | 2001-12-25 | Immunogen, Inc. | Process for the preparation and purification of thiol-containing maytansinoids |
AR030612A1 (es) * | 2000-09-12 | 2003-08-27 | Smithkline Beecham Corp | Procedimiento e intermedios |
US6790954B2 (en) * | 2002-01-29 | 2004-09-14 | Immunogen, Inc. | Mutant Actinosynnema pretiosum strain with increased maytansinoid production |
AU2003257210A1 (en) * | 2002-08-08 | 2004-02-25 | Smithkline Beecham Corporation | Methods for the isolation and purification of ansamitocins |
WO2005020883A2 (en) * | 2003-05-08 | 2005-03-10 | Immunogen, Inc. | Methods for the production of ansamitocins |
US7432088B2 (en) | 2003-05-08 | 2008-10-07 | Immunogen Inc. | Methods for the production of ansamitocins |
US7276497B2 (en) * | 2003-05-20 | 2007-10-02 | Immunogen Inc. | Cytotoxic agents comprising new maytansinoids |
US20070135629A1 (en) * | 2005-12-08 | 2007-06-14 | Millennium Pharmaceuticals, Inc. | Isolation of ansamitocins |
EP1806365A1 (en) | 2006-01-05 | 2007-07-11 | Boehringer Ingelheim International GmbH | Antibody molecules specific for fibroblast activation protein and immunoconjugates containing them |
CN100420754C (zh) * | 2006-10-26 | 2008-09-24 | 浙江海正药业股份有限公司 | 一种制备蒽莎姆菌素的方法 |
US20140105915A1 (en) | 2011-05-27 | 2014-04-17 | Glaxo Group Limited | Bcma (cd269/tnfrsf17) - binding proteins |
CN102505023A (zh) * | 2011-11-18 | 2012-06-20 | 华东理工大学 | 一种dahp合酶的异源可溶性表达方法及其重组载体和基因工程菌 |
CN108276427A (zh) * | 2018-01-14 | 2018-07-13 | 常州大学 | 一种安丝菌素p-3的提取与分离纯化方法 |
CN110117626A (zh) * | 2018-02-06 | 2019-08-13 | 上海键合医药科技有限公司 | 一种制备安丝菌素p3的发酵工艺 |
PL3956332T3 (pl) | 2019-04-18 | 2023-05-29 | Indena S.P.A. | Diastereoselektywny sposób wytwarzania estrów majtanzynoidowych zawierających tiol lub dwusiarczek i ich produkty pośrednie |
CN113444106A (zh) * | 2020-03-25 | 2021-09-28 | 重庆乾泰生物医药有限公司 | 一种高纯度安丝菌素的制备方法 |
WO2022248870A1 (en) | 2021-05-28 | 2022-12-01 | Glaxosmithkline Intellectual Property Development Limited | Combination therapies for treating cancer |
WO2022262591A1 (zh) * | 2021-06-18 | 2022-12-22 | 杭州中美华东制药有限公司 | 安丝菌素p-3的提纯方法 |
WO2023057893A1 (en) | 2021-10-05 | 2023-04-13 | Glaxosmithkline Intellectual Property Development Limited | Combination therapies for treating cancer |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1314019A (en) * | 1969-07-19 | 1973-04-18 | Rolland Sa A | Antibiotic substance and process for the extraction of such an antibiotic substance from a strain of pseudomonas |
ZA737247B (en) | 1972-09-29 | 1975-04-30 | Ayerst Mckenna & Harrison | Rapamycin and process of preparation |
US4162940A (en) | 1977-03-31 | 1979-07-31 | Takeda Chemical Industries, Ltd. | Method for producing Antibiotic C-15003 by culturing nocardia |
JPS6010718B2 (ja) | 1977-03-31 | 1985-03-19 | 武田薬品工業株式会社 | メイタンシノ−ル,メイタナシンおよびメイタンシノ−ル・プロピオネ−トの製造法 |
JPS6016236B2 (ja) | 1977-11-18 | 1985-04-24 | 武田薬品工業株式会社 | 抗生物質c―15003 p―3の製造法 |
JPS55162791A (en) | 1979-06-05 | 1980-12-18 | Takeda Chem Ind Ltd | Antibiotic c-15003pnd and its preparation |
JPS5645483A (en) | 1979-09-19 | 1981-04-25 | Takeda Chem Ind Ltd | C-15003phm and its preparation |
JPS56102793A (en) | 1979-12-28 | 1981-08-17 | Takeda Chem Ind Ltd | Preparation of antibiotic c-15003 p-3 |
US4423211A (en) * | 1981-12-21 | 1983-12-27 | Merck & Co., Inc. | Process for the whole broth extraction of avermectin |
JPH0347090A (ja) * | 1988-12-27 | 1991-02-28 | Takeda Chem Ind Ltd | 二重特異性を有するハイブリッドモノクローナル抗体 |
US5208020A (en) | 1989-10-25 | 1993-05-04 | Immunogen Inc. | Cytotoxic agents comprising maytansinoids and their therapeutic use |
CA2069439A1 (en) | 1989-12-15 | 1991-06-16 | Susumu Iwasa | Monoclonal antibodies, their production and use |
FR2656874B1 (fr) * | 1990-01-11 | 1992-04-03 | Commissariat Energie Atomique | Procede de production et d'extraction d'anti-oxydants a partir d'une culture de micro-organismes et photobioreacteur pour la mise en óoeuvre de ce procede. |
DE4037441A1 (de) * | 1990-11-24 | 1992-05-27 | Basf Ag | Verfahren zur erhoehung des riboflavin-gahaltes in spruehgetrockneten fermenteraustraegen bei riboflavin-fermentationen |
JPH08214870A (ja) * | 1995-02-17 | 1996-08-27 | Kanegafuchi Chem Ind Co Ltd | ファフィア・ロドチーマ酵母の細胞壁処理方法 |
CN1056845C (zh) * | 1995-03-03 | 2000-09-27 | 弗·哈夫曼-拉罗切有限公司 | 核黄素的纯化 |
-
2001
- 2001-04-09 US US09/828,758 patent/US6573074B2/en not_active Expired - Lifetime
- 2001-04-10 AR ARP010101696A patent/AR028002A1/es unknown
- 2001-04-11 CA CA002406188A patent/CA2406188A1/en not_active Abandoned
- 2001-04-11 DE DE60121150T patent/DE60121150T2/de not_active Expired - Lifetime
- 2001-04-11 JP JP2001575214A patent/JP4832697B2/ja not_active Expired - Fee Related
- 2001-04-11 AU AU9333501A patent/AU9333501A/xx active Pending
- 2001-04-11 CZ CZ20023356A patent/CZ20023356A3/cs unknown
- 2001-04-11 AU AU2001293335A patent/AU2001293335B2/en not_active Ceased
- 2001-04-11 WO PCT/GB2001/001661 patent/WO2001077360A2/en active IP Right Grant
- 2001-04-11 KR KR1020027013580A patent/KR20030036159A/ko not_active Application Discontinuation
- 2001-04-11 AT AT01966770T patent/ATE331804T1/de not_active IP Right Cessation
- 2001-04-11 PL PL01365577A patent/PL365577A1/xx not_active Application Discontinuation
- 2001-04-11 ES ES01966770T patent/ES2266243T3/es not_active Expired - Lifetime
- 2001-04-11 NZ NZ521868A patent/NZ521868A/en not_active IP Right Cessation
- 2001-04-11 CN CN01810371A patent/CN1432068A/zh active Pending
- 2001-04-11 EP EP01966770A patent/EP1272653B1/en not_active Expired - Lifetime
- 2001-04-11 MX MXPA02010109A patent/MXPA02010109A/es unknown
- 2001-04-11 IL IL15224101A patent/IL152241A0/xx unknown
- 2001-04-11 HU HU0300473A patent/HUP0300473A3/hu unknown
- 2001-04-11 BR BR0109975-2A patent/BR0109975A/pt not_active Application Discontinuation
-
2002
- 2002-10-10 NO NO20024893A patent/NO20024893D0/no not_active Application Discontinuation
- 2002-10-10 ZA ZA200208159A patent/ZA200208159B/en unknown
-
2003
- 2003-03-04 US US10/379,136 patent/US20030157669A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NO20024893L (no) | 2002-10-10 |
DE60121150D1 (de) | 2006-08-10 |
US6573074B2 (en) | 2003-06-03 |
EP1272653A2 (en) | 2003-01-08 |
CZ20023356A3 (cs) | 2003-04-16 |
WO2001077360A3 (en) | 2002-09-12 |
CN1432068A (zh) | 2003-07-23 |
KR20030036159A (ko) | 2003-05-09 |
PL365577A1 (en) | 2005-01-10 |
AU2001293335B2 (en) | 2005-02-24 |
US20020015984A1 (en) | 2002-02-07 |
NO20024893D0 (no) | 2002-10-10 |
BR0109975A (pt) | 2004-03-23 |
JP4832697B2 (ja) | 2011-12-07 |
ES2266243T3 (es) | 2007-03-01 |
WO2001077360A2 (en) | 2001-10-18 |
DE60121150T2 (de) | 2007-05-16 |
HUP0300473A3 (en) | 2004-07-28 |
MXPA02010109A (es) | 2003-02-12 |
HUP0300473A2 (hu) | 2003-06-28 |
ZA200208159B (en) | 2003-10-17 |
JP2003530114A (ja) | 2003-10-14 |
IL152241A0 (en) | 2003-05-29 |
US20030157669A1 (en) | 2003-08-21 |
ATE331804T1 (de) | 2006-07-15 |
EP1272653B1 (en) | 2006-06-28 |
CA2406188A1 (en) | 2001-10-18 |
AU9333501A (en) | 2001-10-23 |
NZ521868A (en) | 2004-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60205413D1 (de) | Herstellungsverfahren | |
AR027956A1 (es) | Nuevas combinaciones de farmacos | |
DE50115520D1 (de) | Strahlformungsverfahren | |
DE60134167D1 (de) | Stanze | |
AR028002A1 (es) | Metodos para la produccion de ansamitocina | |
DE10196082T1 (de) | FLIP-CHIP-Montageverfahren | |
AR028201A1 (es) | Metodo para aliviar la ansiedad | |
IS6716A (is) | Aðferðir við að framleiða sílostasól | |
DE50100418D1 (de) | Brezelherstellungssystem | |
DE60115364D1 (de) | Herstellungsverfahren für stranggussknüppel | |
AR028078A1 (es) | Proceso para la produccion de grrnulos de enzimas | |
DE50101454D1 (de) | Fertigungsstrassenabschnitt | |
PT1259535E (pt) | Derivados de hexapeptideo ciclico | |
DE60130426D1 (de) | Aluminiumoxid-Leuchtstoff- Herstellungsverfahren | |
AR027987A1 (es) | Un metodo para la preparacion de ciclopropenos | |
AR028550A1 (es) | Procedimiento para la obtencion de caprolactama | |
AR028328A1 (es) | Proceso para la preparacion de heterociclos benzo-fusionados | |
AR028111A1 (es) | Procedimiento para la produccion de isocianatos | |
DE60012372D1 (de) | Verbesserte herstellungsmethode für acylferrocene | |
PT9699T (pt) | Dispositivo retrovisor para ciclistas | |
ES1046497Y (es) | Escurridor para mochos | |
ID29728A (id) | Proses untuk pembuatan piridin-piridin tersubstitusi | |
NO20025598L (no) | Roterende dör | |
ES1046576Y (es) | Bovedilla para forjados | |
AR028548A1 (es) | Procedimiento para la obtencion de caprolactama |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |